Our experience helps healthcare professionals diagnose and treat their patients.

When you rely on the products and services of Fujirebio Diagnostics Inc., you can depend on more than 20 years of experience in assay and clinical development. Our extensive network of clinical investigators includes prestigious academic institutions and medical centers. Our products have been continually proven as thousands of peer-reviewed articles have been published that support our diagnostic products. Our products are also available in a manual assay format (EIA Kits) or as custom-developed products for use through our worldwide network of partners and distributors.

The Core of Our Products

At the heart of Fujirebio Diagnostics’ products are the original Centocor and CanAg antibodies, which form the base of a product line that has been long recognized as the worldwide standard of excellence in cancer biomarkers. Our core technology is based on our proprietary monoclonal antibodies originally developed to detect a variety of tumor markers. These antibodies have been utilized in the past to develop a menu of in vitro diagnostic tests.

Learn more about Fujirebio Diagnostics’ products that are available in the rest of the world:

Oncology and Disease State Products

CA125 + HE4 test combination

A more accurate predictor of malignant disease than either biomarker alone.

Watch our new animation to learn more =>

Laboratory Professionals